西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2014年
5期
104-106
,共3页
李有成%严文有%陈俊英%蔡菊梅
李有成%嚴文有%陳俊英%蔡菊梅
리유성%엄문유%진준영%채국매
溃疡性结肠炎,慢性%加味阳和四神汤%浸膏剂%治疗,临床研究性
潰瘍性結腸炎,慢性%加味暘和四神湯%浸膏劑%治療,臨床研究性
궤양성결장염,만성%가미양화사신탕%침고제%치료,림상연구성
ulcerative colitis,chronic%modified YangHe SiShen decoction%extract%treatment,clinical study
目的:观察加味阳和四神汤/浸膏剂治疗慢性溃疡性结肠炎的临床疗效。方法:将慢性溃疡性结肠炎患者110例随机分为2组,对照组47例予美沙拉嗪片、甲基强的松龙、金双岐片治疗,治疗组63例在对照组治疗的基础上采用加味阳和四神汤/浸膏剂治疗,3个月后观察2组患者CRP、IL-10水平及临床疗效。结果:治疗后2组患者CRP、IL-10水平较治疗前明显降低,且治疗组降低程度高于对照组(P<0.05);2组临床疗效比较差异无统计学意义(P>0.05)。结论:加味阳和四神汤/浸膏剂能降低慢性溃疡性结肠炎患者CRP、IL-10水平。
目的:觀察加味暘和四神湯/浸膏劑治療慢性潰瘍性結腸炎的臨床療效。方法:將慢性潰瘍性結腸炎患者110例隨機分為2組,對照組47例予美沙拉嗪片、甲基彊的鬆龍、金雙岐片治療,治療組63例在對照組治療的基礎上採用加味暘和四神湯/浸膏劑治療,3箇月後觀察2組患者CRP、IL-10水平及臨床療效。結果:治療後2組患者CRP、IL-10水平較治療前明顯降低,且治療組降低程度高于對照組(P<0.05);2組臨床療效比較差異無統計學意義(P>0.05)。結論:加味暘和四神湯/浸膏劑能降低慢性潰瘍性結腸炎患者CRP、IL-10水平。
목적:관찰가미양화사신탕/침고제치료만성궤양성결장염적림상료효。방법:장만성궤양성결장염환자110례수궤분위2조,대조조47례여미사랍진편、갑기강적송룡、금쌍기편치료,치료조63례재대조조치료적기출상채용가미양화사신탕/침고제치료,3개월후관찰2조환자CRP、IL-10수평급림상료효。결과:치료후2조환자CRP、IL-10수평교치료전명현강저,차치료조강저정도고우대조조(P<0.05);2조림상료효비교차이무통계학의의(P>0.05)。결론:가미양화사신탕/침고제능강저만성궤양성결장염환자CRP、IL-10수평。
Objective: To explore therapeutic effects of modified YangHe SiShendecoction or extract in treat-ing chronic ulcerative colitis (CUC). Methods: All 110 patients were randomized into two groups. All 47 patients of the control group took mesalazine tablets, methylprednisolone and live combined bifidobacterium and lactobacillus tablets, 63 cases of the treatment group took modifiedYangHeSiShendecoction or extract on the foundation of the therapy given to the control group, curative effects, the levels of CRP and IL-10 of both groups were observed in three months. Results: The levels of CRP and IL-10 in both groups after treating were decreased more significantly compared with these before treating, the decrease of the treatment group was higher than that of the control group (P<0.05); the difference showed no statistical meaning in clinical effects (P>0.05). Conclusion: ModifiedYangHe SiShendecoction or extract could decrease the levels of CRP and IL-10 in CUC patients.